Estimated mortality and hospital admission due to rotavirus infection in the WHO European region

Epidemiology and Infection

Volumn 137, Issue 5, 2009, Pages 607-616

  Williams, C J ^a,b,d   Lobanov, A ^c   Pebody, R G ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ECDC   (Sweden)

^c WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^d Norfolk Suffolk and Cambridgeshire Health Protection Unit   (United Kingdom)

Author keywords

Europe; Hospitalization; Paediatric; Rotavirus gastroenteritis; Vaccine

Indexed keywords

ACUTE GASTROENTERITIS; CAUSAL ATTRIBUTION; CAUSE OF DEATH; DIARRHEA; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HOSPITAL ADMISSION; HUMAN; INTESTINE INFECTION; LOWEST INCOME GROUP; MORTALITY; REVIEW; ROTAVIRUS; SOCIAL STATUS; VIRUS INFECTION; WORLD HEALTH ORGANIZATION; EUROPE; HOSPITALIZATION; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; NEWBORN; PRESCHOOL CHILD; SOCIOECONOMICS;

ROTAVIRUS VACCINE;

CHILD, PRESCHOOL; EUROPE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SOCIOECONOMIC FACTORS;

EID: 65549116428     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268808001714     Document Type: Review

References (66)

1. Djuretic T, et al. An estimate of the proportion of diarrhoeal disease episodes seen by general practitioners attributable to rotavirus in children under 5 y of age in England and Wales. Acta Paediatrica (Suppl.) 1999; 88: 38-41.
2. Koopmans M, Van Asperen I. Epidemiology of rotavirus infections in The Netherlands. Acta Paediatrica (Suppl. 1) 1999; 88: 31-37.
3. Parashar UD, et al. Global illness and deaths caused by rotavirus disease in children. Emerging Infectious Diseases 2003; 9: 565-572.
4. Ruiz-Palacios GM, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. New England Journal of Medicine 2006; 354: 11-22.
5. Vesikari T, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New England Journal of Medicine 2006; 354: 23-33.
6. European Medicines Agency. European public assessment report: Rotarix. European medicines agency website 2007 (http://www.emea.europa.eu/humandocs/Humans/EPAR/rotarix/rotarix.htm). Accessed December 2007.
7. European Medicines Agency. European public assessment report: Rotateq. European medicines agency website 2007 (http://www.emea.europa.eu/humandocs/Humans/EPAR/rotateq/rotateq.htm). Accessed December 2007.
8. Soriano-Gabarro M, et al. Burden of rotavirus disease in European Union countries. Pediatric Infectious Diseases Journal 2006; 25 (Suppl.): S7-S11.
9. Semenza JC, et al. Water distribution system and diarrheal disease transmission: A case study in Uzbekistan. American Journal Tropical Medicine and Hygiene 1998; 59: 941-946.
10. WHO. European Health for All database. World Health Organisation, 2006 (http://www.euro.who.int/hfadb). Accessed December 2007.
11. WHO Regional Office for Europe. European hospital morbidity database, 2007 (http://www.euro.who.int/datapublications/Data/ 20061120_1). Copenhagen, Denmark.
12. World Bank website. World Development Indicators Online (WDI). World Bank, 2007. (http://ddp-ext.worldbank.org/ext/DDPQQ/ member.do?method=getMembers). Accessed December 2007.
13. Ryndich AA, et al. Rotavirus gastroenteritis in different regions of Russia [in Russian]. Zhurnal mikrobiologii, epidemiologii i immunobiologii 1993; 6: 40-41.
14. Solodovnikov I, et al. Rotavirus gastroenteritis: The status of the problem in Moscow [in Russian]. Zhurnal mikrobiologii, epidemiologii i immunobiologii 1999; 6: 121.
15. Amar CF, et al. Detection by PCR of eight groups of enteric pathogens in 4627 faecal samples: Reexamination of the English case-control Infectious Intestinal Disease Study (1993-1996). European Journal of Clinical Microbiology and Infectious Diseases 2007; 26: 311-323.
16. WHO. Core health indicators, 2006. World Health Organisation Statistical Information System.
17. WHO. The World health report 2006: Working together for health, 2006. Geneva: World Health Organization.
18. Bryce J, et al. WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet 2005; 365: 1147-1152.
19. WHO. WHO mortality profiles. World Health Organisation website 2007 (http://www.who.int/whostatistics/mortality). Accessed December 2007.
20. World Population Prospects. The 2006 revision population database. United Nations population division, 2006 (http://esa.un.org/unpp/). Accessed December 2007.
21. WHO. European Health for All mortality database. World Health Organization, 2006 (http://www.euro.who.int/hfadb). Accessed December 2007.
22. Isakbaeva ET, et al. Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine. Vaccine 2007; 25: 373-380.
23. WHO. Causes of death among children under five years of age (percentage). World Health Organisation Statistical Information System Indicator definitions and metadata, 2006 (http://www.who.int/whosis/ whostat2006CausesOfDeathUnder5.pdf). Accessed December 2007.
24. Williams CJ, et al. Survey of rotavirus surveillance, laboratory capacity and disease burden in the eastern part of the WHO European Region. Eurosurveillance 2008; 13(34) (http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18959).
25. Tran Minh NN. Survey of the deaths due to acute gastro-enteritis avoidable with the rotavirus vaccine, France, November 2004-March 2005. Poster presentation at 2006 EPIET Scientific seminar.
26. Jit M, et al. Estimating the number of deaths with rotavirus as a cause in England and wales. Human Vaccines 2007; 3: 23-26.
27. GAVI Alliance. Eligible countries. GAVI alliance 2007 (http://www.gavialliance.org/support/who/eligible/index.php). Accessed December 2007.
28. Turkish Ministry of Health. Refik Saydam Hygiene centre presidency, School of public health BU. National burden of disease and cost effectiveness project: Burden of disease final report, 2004.
29. Hacettepe University Institute of Population Studies. General Directorate of Mother and Child Health/Family Planning MoH. Turkey demographic and health survey, 2003. Institute of Population Studies, 2004 (http://www.hips.hacettepe.edu.tr/tnsa2003eng/reports.htm). Accessed December 2007.
30. Takala AK, et al. Economic evaluation of rotavirus vaccinations in Finland: Randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine. Clinical Infectious Diseases 1998; 27: 272-282.
31. New Medicine. Rotarix. Pharmaceutical Journal 2006; 276 619.
32. Lob-Levyt J. Re: 2007 Update on support to countries from the GAVI alliance. GAVI Alliance, 2007.
33. Rafiev K. The spread of rotavirus gastroenteritis in the Republic of Tajikistan. Zhurnal mikrobiologii epidemiologii i immunobiologii 1999; 3: 26-28.
34. Isakbaeva ET, et al. Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine. Vaccine 2007; 25: 373-380.
35. Ahmetagic S, et al. Acute infectious diarrhea in children. Medicinski Arhiv 2003; 57: 87-92.
36. Diamanti E, et al. An epidemiological study on viral infantile diarrhoea in Tirana. New Microbiologica 1996; 19: 9-14.
37. Superti F, et al. Electropherotypes of rotavirus strains causing gastroenteritis in infants and young children in Tirana, Albania, from 1988 to 1991. Acta Virologica (English edn), 1995; 39: 257-261.
38. David E, et al. The etiology of acute diarrheal diseases in hospitalized children and as outpatients. Bacteriologia Virusologia Parazitologia Epidemiologia 1996; 41: 37-41.
39. Kurugol Z, et al. Rotavirus gastroenteritis among children under five years of age in Izmir, Turkey. Turkish Journal of Paediatrics 2003; 45: 290-294.
40. Karadag A, et al. Childhood diarrhoea in Ankara, Turkey: epidemiological and clinical features of rotavirus-positive versus rotavirus-negative cases. Scandinavian Journal of Infectious Diseases 2005; 37: 269-275.
41. Mrukowicz JZ, et al. Epidemiology and impact of rotavirus diarrhoea in Poland. Acta Paediatrica (Suppl.) 1999; 88: 53-60.
42. Szücs G, et al. Burden of human rotavirus-associated hospitalizations in three geographic regions of Hungary. Acta Paediatrica (Suppl.) 1999; 88: 61-65.
43. Banyai K, et al. Survey of rotavirus infection in a Hungarian paediatric hospital. A short communication. Acta Microbiologica et Immunologica Hungarica 2004; 51: 431-435.
44. Ginevskaya VA, et al. Electropherotypes and serotypes of human rotavirus in Estonia. Archives of Virology 1994; 137: 199-207.
45. Pazdiora P. Diagnosis of rotavirus infections in 2004, major characteristics in 1998-2004 in the Czech Republic [in Czech]. Epidemiologie Mikrobiologie Imunologie 2006; 55: 32-36.
46. Pazdiora P. Diagnosis of rotavirus infections and their reporting in the Czech Republic in 2001 [in Czech]. Epidemiologie Mikrobiologie Imunologie 2003; 52: 9-12.
47. Steyer A, et al. The emergence of rotavirus genotype G9 in hospitalised children in Slovenia. Journal of Clinical Virology 2005; 33: 7-11.
48. Kafetzis DA, et al. Epidemiology, clinical course and impact on hospitalization costs of acute diarrhea among hospitalized children in Athens, Greece. Scandinavian Journal of Infectious Diseases 2001; 33: 681-685.
49. Van DP, et al. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: The REVEAL study. Journal of Infectious Diseases 2007; 195 (Suppl. 1): S4-S16.
50. Diez-Domingo J, et al. Rotavirus gastroenteritis among children under five years of age in Valencia, Spain. Pediatric Infectious Disease Journal 2006; 25: 455-457.
51. Cilla G, et al. Incidence, seasonality and serotypes of rotavirus in Gipuzkoa (Basque Country), Spain. A 14-year study. Epidemiology and Infection 2000; 125: 677-683.
52. Visser LE, et al. Impact of rotavirus disease in Spain: An estimate of hospital admissions due to rotavirus. Acta Paediatrica (Suppl.), 1999; 88: 72-76.
53. Sanchez F, et al. Diversity of group A human rotavirus types circulating over a 4-year period in Madrid, Spain. Journal of Clinical Microbiology 2004; 42: 1609-1613.
54. Gabutti G, et al. Epidemiology and burden of rotavirus-associated hospitalizations in Ferrara, Italy. Journal of Preventive Medicine and Hygiene 2007; 48: 5-9.
55. Caprioli A, et al. Enteropathogens associated with childhood diarrhea in Italy. The Italian Study Group on Gastrointestinal Infections. Pediatric Infectious Disease Journal 1996; 15: 876-883.
56. Berner R, Schumacher RF, Forster J. Survey on rotavirus infections in a German pediatric hospital. European Journal of Clinical Microbiology & Infectious Diseases 1997; 16: 479-481.
57. Berner R, et al. Occurrence and impact of community-acquired and nosocomial rotavirus infections - a hospital-based study over 10 y. Acta Paediatrica (Suppl.) 1999; 88: 48-52.
58. Ryan MJ, et al. Hospital admissions attributable to rotavirus infection in England and Wales. Journal of Infectious Diseases 1996; 174 (Suppl. 1): S12-S18.
59. Vesikari T, Rautanen T, Von B. Rotavirus gastroenteritis in Finland: Burden of disease and epidemiological features. Acta Paediatrica (Suppl.), 1999; 88: 24-30.
60. de Wit, Koopmans MP, et al. Hospital admissions for rotavirus infection in the Netherlands. Clinical Infectious Diseases 2000; 31: 698-704.
61. Johansen K, et al. Incidence and estimates of the disease burden of rotavirus in Sweden. Acta Paediatrica (Suppl.), 1999; 88: 20-23.
62. Fischer TK. Incidence of hospitalizations due to rotavirus gastroenteritis in Denmark. Acta Paediatrica 2001; 90: 1073-1075.
63. Fischer TK, et al. Incidence and cost of rotavirus hospitalizations in Denmark. Emerging Infectious Diseases 2007; 13: 855-859.
64. Lynch M, et al. Rotavirus in Ireland: National estimates of disease burden, 1997 to 1998. Pediatric Infectious Disease Journal 2001; 20: 693-698.
65. O'Mahony J, et al. Rotavirus gastroenteritis among paediatric patients at Tralee General Hospital. Irish Medical Journal 2000; 93: 274-277.
66. Bucher B, Aebi C. Population-based epidemiology of rotavirus hospitalisations in Switzerland. Swiss Medical Weekly 2006; 136 726-731.